These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 5859368)

  • 21. DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF SERUM ENZYMES. II. NEUROLOGIC DISEASES OTHER THAN MUSCULAR DYSTROPHY.
    FOWLER WM; PEARSON CM
    Arch Phys Med Rehabil; 1964 Mar; 45():125-30. PubMed ID: 14127954
    [No Abstract]   [Full Text] [Related]  

  • 22. Pyruvate kinase isoenzymes in progressive muscular dystrophy and in acute myocardial infarction.
    Harano Y; Adair R; Vignos PJ; Miller M; Kowal J
    Metabolism; 1973 Mar; 22(3):493-501. PubMed ID: 4690655
    [No Abstract]   [Full Text] [Related]  

  • 23. [Creatine phosphokinase as an indication of muscular damage].
    Schaposnik F; Salvioli MV; Laguens R; Neuman M; Cacciatore J
    Rev Clin Esp; 1970 Jan; 116(1):29-32. PubMed ID: 5419147
    [No Abstract]   [Full Text] [Related]  

  • 24. [Biological anomalies in the apparently healthy transmitters of muscular dystrophy].
    DEMOS J; DREYFUS JC; SCHAPIRA F; SCHAPIRA G
    Rev Can Biol; 1962; 21():587-97. PubMed ID: 14026924
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
    Ceccarelli A; Leone P
    Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
    [No Abstract]   [Full Text] [Related]  

  • 26. [Serum enzyme activities in the families of patients with progressive muscular dystrophy].
    Tani J; Yano I; Masaki H; Fukuyama K; Saeki B
    Iryo; 1967 Jul; 21(7):848-53. PubMed ID: 5582480
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of myopathy at Duchenne de Boulogne: results obtained at specialized center].
    Demos J; Laqueche A; Fourquet D
    Arch Fr Pediatr; 1968 Feb; 25(2):163-79. PubMed ID: 4386468
    [No Abstract]   [Full Text] [Related]  

  • 28. Quantitative strength measurements in muscular dystrophy.
    Fowler WM; Gardner GW
    Arch Phys Med Rehabil; 1967 Dec; 48(12):629-44. PubMed ID: 6073414
    [No Abstract]   [Full Text] [Related]  

  • 29. [Contribution to the study of the enzymology of primary myopathies of childhood].
    Vitetta M
    Biol Lat; 1965; 18(4):359-66. PubMed ID: 5871253
    [No Abstract]   [Full Text] [Related]  

  • 30. [DIAGNOSTIC SIGNIFICANCE OF THE SERUM ALDOLASE ACTIVITY IN PROGRESSIVE MUSCULAR DYSTROPHY IN CHILDHOOD].
    WILUTZKY H
    Monatsschr Kinderheilkd (1902); 1964 Aug; 112():366-9. PubMed ID: 14259613
    [No Abstract]   [Full Text] [Related]  

  • 31. [STUDY OF SIDEREMIA, ALDOLASEMIA AND TRANSMINASEMIA IN MORE THAN 100 MYOPATHIC PATIENTS IN BASIC CONDITIONS AND AFTER RE-METABOLIZING THERAPY].
    BUSCAINO GA; SPADETTA V; SEPE O
    Rass Med Sarda; 1964; 66():143-55. PubMed ID: 14221414
    [No Abstract]   [Full Text] [Related]  

  • 32. [Enzyme activity determination in progressive muscular dystrophy. IV. Serum enzymatic kinetics in the preclinical stage of the Duchenne type during the 1st 2 years of life].
    Heyck H; Laudahn G; Carsten PM
    Klin Wochenschr; 1966 Jun; 44(12):695-700. PubMed ID: 5990806
    [No Abstract]   [Full Text] [Related]  

  • 33. MYOPATHIC CHANGES IN A MUSCULAR DYSTROPHY CARRIER.
    DUBOWITZ V
    J Neurol Neurosurg Psychiatry; 1963 Aug; 26(4):322-5. PubMed ID: 14043046
    [No Abstract]   [Full Text] [Related]  

  • 34. [Allopurinol in progressive muscular dystrophy (author's transl)].
    Castro-Gago M; Jiménez JF; Torres-Colomer M; Fuster M; Paz M; Novo I; Peña J
    An Esp Pediatr; 1980 Oct; 13(10):865-76. PubMed ID: 7469188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GLYCOGEN, CREATINE, AND HIGH ENERGY PHOSPHATE IN HUMAN MUSCLE DISEASE.
    VIGNOS PJ; WARNER JL
    J Lab Clin Med; 1963 Oct; 62():579-90. PubMed ID: 14080857
    [No Abstract]   [Full Text] [Related]  

  • 36. Investigation on healthy individuals from families of patients with Duchenne type muscular dystrophy.
    Hausmanowa-Petrusewicz I; Prot J; Niebrój-Dobosz I; Emeryk B; Wasowicz B; Slucka C; Hetnarska L; Bendarzewska B; Pucek Z
    Pol Med J; 1968; 7(1):228-37. PubMed ID: 5652928
    [No Abstract]   [Full Text] [Related]  

  • 37. [Neonatal screening for duchenne myopathy by serum elevation of creatine phosphokinase activity. 5 years experience].
    Plauchu H; Dellamonica C; Pascal B; Jolivet MJ; Guibaud P; Cotte J; Robert JM
    J Genet Hum; 1981 Mar; 29(1):59-69. PubMed ID: 7334342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [SERUM CREATINE KINASE IN MYOPATHIC MICE].
    SCHAPIRA F; DREYFUS JC
    Enzymol Biol Clin (Basel); 1963; 79():53-7. PubMed ID: 14056981
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chronic progressive external ophthalmoplegia in the current views of isolated and evolutive ocular myopathy. Diagnostic and prognostic judgment by means of electromyography and determination of muscle enzymes in the blood].
    Morra M
    Minerva Oftalmol; 1970; 12(2):47-58. PubMed ID: 5507455
    [No Abstract]   [Full Text] [Related]  

  • 40. Newer serum enzyme determinations as aids in diagnosis.
    Med Lett Drugs Ther; 1967 Jan; 9(1):3-4. PubMed ID: 6040594
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.